Search Results - "Paterson, Louise M"

Refine Results
  1. 1

    Re-evaluating our focus in addiction: emotional dysregulation is a critical driver of relapse to drug use by Hand, Lexi J., Paterson, Louise M., Lingford-Hughes, Anne R.

    Published in Translational psychiatry (09-11-2024)
    “…Most addiction research has focused on reward- and impulsivity-related neurocircuitry. However, the impact of the withdrawal/negative affect stage in the…”
    Get full text
    Journal Article
  2. 2

    Measuring endogenous 5-HT release by emission tomography: promises and pitfalls by Paterson, Louise M, Tyacke, Robin J, Nutt, David J, Knudsen, Gitte M

    “…Molecular in vivo neuroimaging techniques can be used to measure regional changes in endogenous neurotransmitters, evoked by challenges that alter synaptic…”
    Get full text
    Journal Article Book Review
  3. 3

    Sleep and its disorders in translational medicine by Paterson, Louise M, Nutt, David J, Wilson, Sue J

    Published in Journal of psychopharmacology (Oxford) (01-09-2011)
    “…The study of sleep is a useful approach to studying the brain in psychiatric disorders and in investigating the effects of psychotropic drugs. Sleep physiology…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

    A translational, caffeine-induced model of onset insomnia in rats and healthy volunteers by PATERSON, Louise M, WILSON, Sue J, NUTT, David J, HUTSON, Peter H, IVARSSON, Magnus

    Published in Psychopharmacologia (01-05-2007)
    “…Insomnia is a common and disabling complaint for which there is a need for improved treatments. Successful drug discovery relies on the use of appropriate…”
    Get full text
    Journal Article
  9. 9

    5-HT radioligands for human brain imaging with PET and SPECT by Paterson, Louise M., Kornum, Birgitte R., Nutt, David J., Pike, Victor W., Knudsen, Gitte M.

    Published in Medicinal research reviews (01-01-2013)
    “…The serotonergic system plays a key modulatory role in the brain and is the target for many drug treatments for brain disorders either through reuptake…”
    Get full text
    Journal Article
  10. 10
  11. 11

    A dose‐finding design for dual‐agent trials with patient‐specific doses for one agent with application to an opiate detoxification trial by Mozgunov, Pavel, Cro, Suzie, Lingford‐Hughes, Anne, Paterson, Louise M., Jaki, Thomas

    “…There is a growing interest in early phase dose‐finding clinical trials studying combinations of several treatments. While the majority of dose finding designs…”
    Get full text
    Journal Article
  12. 12
  13. 13

    NAPSAQ-1: National Patient Sleep Assessment Questionnaire in depression by Paterson, Louise M, Nutt, David J, Wilson, Sue J

    “…Objectives. Sleep disturbance is a common feature of depression. Symptoms often persist after treatment of the depressive episode, representing a risk factor…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20